Regulation of megakaryocyte maturation and platelet formation, J. Thromb. Haemost, vol.7, issue.1, pp.227-234, 2009. ,
The cellular geography of aurora kinases, Nat. Rev. Mol. Cell Biol, vol.4, pp.842-854, 2003. ,
, CellProfiler: image analysis software for identifying and quantifying cell phenotypes, 2006.
, Genome Biol, vol.7, p.100
Aurora-A kinase is essential for bipolar spindle formation and early development, Mol. Cell. Biol, vol.29, pp.1059-1071, 2009. ,
Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells, Mol. Cancer Ther, vol.7, pp.1140-1149, 2008. ,
Aurora kinase-A regulates microtubule organizing center (MTOC) localization, chromosome dynamics, and histone-H3 phosphorylation in mouse oocytes, Mol. Reprod. Dev, vol.78, pp.80-90, 2011. ,
, , 2005.
, A small molecule-kinase interaction map for clinical kinase inhibitors, Nat. Biotechnol, vol.23, pp.329-336
A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma, Blood, vol.115, pp.5202-5213, 2010. ,
Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout, Blood, vol.111, pp.596-604, 2008. ,
Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor, J. Neurochem, vol.81, pp.9-16, 2002. ,
A quantitative analysis of kinase inhibitor selectivity, Nat. Biotechnol, vol.26, pp.127-132, 2008. ,
Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656, Blood, vol.105, pp.3875-3878, 2005. ,
Increased megakaryocytopoiesis in Lyn-deficient mice, Oncogene, vol.25, pp.3316-3324, 2006. ,
Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1, Nat. Genet, vol.37, pp.613-619, 2005. ,
Aurora kinase inhibitors as anticancer therapy, Anticancer Drugs, vol.21, pp.339-350, 2010. ,
Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process, Blood, vol.116, pp.2345-2355, 2010. ,
Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia, Nat. Genet, vol.28, pp.220-221, 2001. ,
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL, Cancer Cell, vol.20, pp.357-369, 2011. ,
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome, Blood, vol.113, pp.2619-2628, 2009. ,
Characterization of alisertib (MLN8237), an investigational small molecule inhibitor of Aurora A kinase using novel in vivo pharmacodynamic assays, Clin. Cancer Res, vol.17, pp.7614-7624, 2011. ,
The protein kinase complement of the human genome, Science, vol.298, pp.1912-1934, 2002. ,
Empirical Bayes analysis of quantitative proteomics experiments, PLoS ONE, vol.4, p.7454, 2009. ,
Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP). Pediatr, Blood Cancer, vol.55, pp.26-34, 2010. ,
Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia, Proc. Natl. Acad. Sci. USA, vol.98, pp.5776-5779, 2001. ,
The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model, J. Clin. Invest, vol.119, pp.852-864, 2009. ,
Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase, J. Med. Chem, vol.50, pp.2213-2224, 2007. ,
Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization, Blood, vol.109, pp.5199-5207, 2007. ,
Identifying the proteins to which small-molecule probes and drugs bind in cells, Proc. Natl. Acad. Sci. USA, vol.106, pp.4617-4622, 2009. ,
Analyzing protein lists with large networks: edge-count probabilities in random graphs with given expected degrees, J. Comput. Biol, vol.12, pp.113-128, 2005. ,
Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia, Br. J. Haematol, vol.72, pp.184-190, 1989. ,
Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237, ACS Chem. Biol, vol.5, pp.563-576, 2010. ,
Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1, Blood, vol.107, pp.87-97, 2006. ,
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience, Blood, vol.96, pp.2405-2411, 2000. ,
Target deconvolution strategies in drug discovery, Nat. Rev. Drug Discov, vol.6, pp.891-903, 2007. ,
Reactome: a knowledge base of biologic pathways and processes, Genome Biol, vol.8, p.39, 2007. ,
ROCK1 functions as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability, Blood, vol.115, pp.1785-1796, 2010. ,
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome, Nat. Genet, vol.32, pp.148-152, 2002. ,
Normal and malignant megakaryopoiesis, Expert Rev. Mol. Med, vol.13, p.32, 2011. ,
Survivin is not required for the endomitotic cell cycle of megakaryocytes, Blood, vol.114, pp.153-156, 2009. ,
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis, Clin. Cancer Res, vol.13, pp.3682-3688, 2007. ,
A simple statistical parameter for use in evaluation and validation of high throughput screening assays, J. Biomol. Screen, vol.4, pp.67-73, 1999. ,